Professor Paul Shiels, Professor of Gerosicence, Section of Healthy Ageing, School of Molecular Biosciences, MVLS, University of Glasgow
Paul Shiels is Professor of Geroscience at the University of Glasgow. He is founder and Director of the Glasgow Geroscience Group. He has over 200 publications and generated 10 Patents in this field. Paul was a pioneer of telomere cloning and worked on ageing in cloned animals, including Dolly the sheep, at PPL Therapeutics Roslin. He has also pioneered the concept of the exposome of ageing and was subsequently the first to describe links between socioeconomic position, epigengetics, the microbiome and ageing. His ideas have been successfully tested in clinical trials. His current research portfolio comprises investigation of the exposome of ageing, novel senotherapies and development of biomarkers of ageing, including epigenetic clocks for normative ageing.
Paul is Chair of the Scientific Advisory Board of the British Society for Research on Ageing, the world’s oldest charitable society for research on ageing. He has acted as an expert on the Biology of Ageing on a number of national policy advising consortia, including providing evidence to the UK Government All Party Parliamentary Group on Longevity. He acts as Chair and as a panel member for a range of National and International Research Council panels.
Paul has acted as CSO for Pathfinder Cell Therapy PLC and sits on the Scientific Advisory Boards and acts as a consultant for a range of Pharma companies. He has a proven track record in public dissemination of his research, including the provision of expert commentary for the BBC and ABC TV networks and as a Panellist at the Edinburgh International Science Festival and the Edinburgh International Book Festival.